AC Immune SA Share Price
NASDAQ: ACIUAC Immune SA Stock Performance
AC Immune SA Share Price Today
As of 30 October 2026, AC Immune SA's share price is $2.37. The stock opened at $2.32, compared to its previous close of $2.37. During today's trading session, AC Immune SA's share price traded between $2.32 and $2.42, with an average price of $2.37. Over the past 52 weeks, the stock has recorded a high of $3.99 and a low of $2.04. In terms of performance, AC Immune SA's share price has declined by 22.20% over the last six months and is down 30.03% on a year-on-year basis.
AC Immune SA Share Price Chart
AC Immune SA Annual Profit & Loss
All figures in USD
About AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
AC Immune SA Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.65 | $2.38 | -9.51% |
Sep 2026 | $2.64 | $2.63 | -2.23% |
Aug 2026 | $2.20 | $2.69 | +22.83% |
Jul 2026 | $2.31 | $2.19 | -8.18% |
Jun 2026 | $2.60 | $2.38 | -10.17% |
May 2026 | $3.06 | $2.65 | -12.66% |
Apr 2026 | $2.89 | $3.04 | +10.55% |
Mar 2026 | $2.83 | $2.75 | -6.46% |
Feb 2026 | $3.22 | $2.94 | -7.40% |
Jan 2026 | $3.19 | $3.17 | +1.28% |
Dec 2025 | $2.95 | $3.13 | +5.56% |
Nov 2025 | $3.29 | $2.97 | -12.13% |